Daily Archives: October 30, 2014

Irvine Pharmaceutical Services Announces the Opening of an Analytical Facility in Hangzhou, China

IRVINE, Calif., Oct. 30, 2014 /PRNewswire/ — Irvine Pharmaceutical Services, Inc., a leading provider in cGMP contract development and parenteral manufacturing services, announces plans to open a new facility in Hangzhou, China.…

Frost & Sullivan Commends Draeger’s Strategic Excellence in Offering an Extensive Solution Line for the Ventilation, Anesthesia and Monitoring Markets

– Draeger is currently working on innovative technologies that will improve the control of ventilation equipment for patients in critical care MOUNTAIN VIEW, Calif., Oct. 30, 2014 /PRNewswire/ — Based on…

Yew Bio-Pharm Applauds China State Forestry Administration’s Creation of Subsidies to Encourage Chinese Medicinal Herb Crops

HARBIN, China, October 30, 2014 /PRNewswire/ — Yew Bio-Pharm Group, Inc. (“Yew Bio” or the “Company”) (OTCBB: YEWB), a major grower and seller of yew trees, yew raw materials used…

China Biologic to Report Third Quarter 2014 Financial Results

BEIJING, October 30, 2014 /PRNewswire/ — China Biologic Products, Inc. (NASDAQ: CBPO, “China Biologic” or the “Company”), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the…

WuXi AppTec Launches Representative Office in Israel, Forms Strategic Collaboration with Pontifax

SHANGHAI, October 30, 2014 /PRNewswire/ — WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology, and medical device industries, with…

Electronic Health Record Usability: CIOs Weigh In

— Frost & Sullivan: Enabling speedy and precise information retrieval is a priority for EHR vendors MOUNTAIN VIEW, Calif., Oct. 30, 2014 /PRNewswire/ — Electronic health records uptake in the U.S.…

TWi Pharmaceuticals Receives US FDA Approval on Generic Donepezil Hydrochloride Tablets USP, 23 mg, its fifth ANDA from US FDA

TAIPEI, October 30, 2014 /PRNewswire/ — TWi Pharmaceuticals, Inc. today announced that it has received final approval from the United States Food and Drug Administration (FDA) on its Abbreviated New…

Protection Against Norovirus by Human-Milk-Oligosaccharides

Federal Ministry of Education and Research supports Development of Norovirus Prophylaxis by Jennewein Biotechnologie RHEINBREITBACH, Germany, Oct. 30, 2014 /PRNewswire/ — Norovirus is the most common cause of viral epidemic…

Lakeland Industries Provides Update on Business Activity Relating to Ebola Crisis

RONKONKOMA, New York, Oct. 30, 2014 /PRNewswire/ — Lakeland Industries, Inc. (NASDAQ: LAKE), a leading global manufacturer of industrial protective clothing for industry, municipalities, healthcare and to first responders on the…